Provention Bio Inc (NASDAQ:PRVB)

Delayed Data
As of Jan 14
 +0.11 / +2.37%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Provention Bio Inc have a median target of 16.00, with a high estimate of 25.00 and a low estimate of 8.00. The median estimate represents a +235.43% increase from the last price of 4.77.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Provention Bio Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.32%
Growthannually 1.06%


Growthquarterly -18.08%
Growthannually --
Key to the earnings and sales forecast charts.